Diversity does make a difference: Fibroblast growth factor-heparin interactions

Current Opinion in Structural Biology

Volumn 8, Issue 5, 1998, Pages 578-586

  Faham, Salem ^a   Linhardt, Robert J ^b   Rees, Douglas C ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARIN; MEMBRANE ENZYME; OLIGOSACCHARIDE; PROTEIN TYROSINE KINASE; PROTEOGLYCAN;

CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; DRUG ACTIVITY; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; STOICHIOMETRY;

EID: 0031733974     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(98)80147-4     Document Type: Article

References (47)

1. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 11:1997;51-59.
2. Conrad HE. Heparin-binding Proteins. 1998;Academic Press, San Diego.
3. Mason IJ. The ins and outs of fibroblast growth factors. Cell. 78:1994;547-552.
4. Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9:1995;919-925.
5. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int. 19:1995;431-444.
6. Galzie Z, Kinsella AR, Smith JA. Fibroblast growth factors and their receptors. Biochem Cell Biol. 75:1997;669-685.
7. McKeehan WL, Wang F, Kan M. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog Nuc Acid Res Mol Biol. 59:1998;135-176.
8. Ohbayashi N, Hoshikawa M, Kimura S, Yamasaki M, Fukui S, Itoh N. Structure and expression of the mRNA encoding a novel fibroblast growth factor, FGF-18. J Biol Chem. 273:1998;18161-18164.
9. Ornitz DM, Xu JS, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G-X, Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem. 271:1996;15292-15297.
10. Kan M, Wang F, Xu J, Crabb JW, Hou J, McKeehan WL. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science. 259:1993;1918-1921.
11. Kan M, Wang F, Kan M, To B, Gabriel JL, McKeehan WL. Divalent cations and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex. J Biol Chem. 271:1996;26143-26148.
12. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol. 12:1992;240-247.
13. Mach H, Volkin DB, Burke CJ, Middaugh CR, Linhardt RJ, Fromm JR, Loganathan D, Mattsson L. Nature of the interaction of heparin with acidic fibroblast growth factor. Biochemistry. 32:1993;5480-5489.
14. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation and cell proliferation. Cell. 79:1994;1015-1024.
15. Thompson LD, Pantoliano MW, Springer BA. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry. 33:1994;3831-3840.
16. Waksman G, Herr AB. New insights into heparin-induced FGF oligomerization. of outstanding interest Nat Struct Biol. 5:1998;527-530 A very clear analysis of the interactions between FGF and heparin fragments or heparin analogs, emphasizing the structural basis of heparin-induced FGF oligomerization.
17. Mohammadi M, Schlessinger J, Hubbard SR. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell. 86:1996;577-587.
18. Lindahl U. Heparin. 1989;CRC Press, Boca Raton, Florida.
19. Stringer SE, Gallagher JT. Heparan sulphate. Int J Biochem Cell Biol. 29:1997;709-714.
20. Zhu X, Komiya H, Chirino A, Faham S, Fox GM, Arakawa T, Hsu BT, Rees DC. Three-dimensional structures of acidic and basic fibroblast growth factors. Science. 251:1991;90-93.
21. Blaber M, Disalvo J, Thomas KA. X-ray crystal structure of human acidic fibroblast growth factor. Biochemistry. 35:1996;2086-2094.
22. Ago H, Kitagawa Y, Fujishima A, Matsuura Y, Katsube Y. Crystal structure of basic fibroblast growth factor at 1.6 Å resolution. J Biochem. 110:1991;360-363.
23. Eriksson AE, Cousens LS, Weaver LH, Matthews BW. Three-dimensional structure of human basic fibroblast growth factor. Proc Natl Acad Sci USA. 88:1991;3441-3445.
24. Zhang J, Cousens LS, Barr PJ, Sprang SR. Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1β Proc Natl Acad Sci USA. 88:1991;3446-3450.
25. Moy FJ, Seddon AP, Bohlen P, Powers R. High resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resolution spectroscopy. Biochemistry. 35:1996;13552-13561.
26. Murzin AG, Lesk AM, Chothia C. Beta trefoil fold patterns of structure and sequence in the Kunitz inhibitors, interleukins-1β and 1α and the fibroblast growth factors. J Mol Biol. 223:1992;531-543.
27. Li L-Y, Safran M, Aviezer D, Bohlen P, Seddon AP, Yayon A. Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction and in vitro angiogenesis. Biochemistry. 33:1994;10999-11007.
28. Walker A, Turnbull JE, Gallagher JT. Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. J Biol Chem. 269:1994;931-935.
29. Moy FJ, Safran M, Seddon AP, Kitchen D, Bohlen P, Aviezer D, Yayon A, Powers R. Properly oriented heparin - decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. of special interest Biochemistry. 36:1997;4782-4791 NMR spectroscopy methods were used to characterize the dynamics of FGF-2 - heparin interactions in order to infer information concerning the structural organization of different complexes. This paper proposes an inactive trans and active cis dimer model for FGF-2 binding to heparin.
30. Wang H, Toida T, Kim YS, Capila I, Hileman RE, Bernfield M, Linhardt RJ. Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding. Biochem Biophys Res Commun. 235:1997;369-373. [Published erratum appears in Biochem Biophys Res Commun 1997, 242:248.].
31. Zhou F-Y, Kan M, Owens RT, McKeehan WL, Thompson JA, Linhardt RJ, Höök M. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides. Eur J Cell Biol. 73:1997;71-80.
32. Ornitz DM, Herr AB, Nilsson M, Westman J, Svahn C-M, Waksman G. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science. 268:1995;432-436.
33. Ishihara M, Tyrell DJ, Stauber GB, Brown S, Cousens LS, Stack RJ. Preparation of affinity fractionated, heparin derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. J Biol Chem. 268:1993;4675-4683.
34. Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem. 269:1994;114-121.
35. Gambarini AG, Miyamoto CA, Lima GA, Nader HB, Dietrich CP. Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate. Mol Cell Biochem. 124:1993;121-129.
36. Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC. Heparin structure and interactions with basic fibroblast growth factor. Science. 271:1996;1116-1120.
37. Zhu X, Hsu BT, Rees DC. Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor. Structure. 1:1993;27-34.
38. DiGabriele AD, Lax I, Chen DI, Svahn CM, Jaye M, Schlessinger J, Hendrickson WA. Structure of a heparin-linked biologically-active dimer of fibroblast growth factor. of outstanding interest Nature. 393:1998;812-817 The first high resolution structure revealing how heparin bridges two FGF-1 molecules, forming a dimer in the absence of protein - protein interactions. The structural basis for the ability of FGF to utilize one binding site in order to interact with heparin in two different orientations is illustrated.
39. Mulloy B, Forster MJ, Jones C, Davies DB. NMR and molecular-modeling studies of the solution conformation of heparin. Biochem J. 293:1993;849-858.
40. Mikhailov D, Linhardt RJ, Mayo KH. NMR solution conformation of heparin-derived hexasaccharide. of outstanding interest Biochem J. 328:1997;51-61 The solution structure and dynamics of a heparin-derived oligosaccharide were determined. This demonstrates the power of NMR methods in identifying and characterizing the presence of multiple conformations.
41. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). J Biol Chem. 268:1993;23906-23914.
42. Reichslotky R, Bonnehbarkay D, Shaoul E, Bluma B, Svahn CM, Ron D. Differential effect of cell associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor. J Biol Chem. 269:1994;32279-32285.
43. Zhou F-Y, Owens RT, Hermonen J, Jalkanen M, Höök M. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans? Eur J Cell Biol. 73:1997;166-174.
44. Ishihara M, Karyia Y, Kikuchi H, Minamisawa T, Yoshida K. Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. J Biochem. 121:1997;345-349.
45. Venkataraman G, Sasisekharan V, Herr AB, Ornitz DM, Waksman G, Cooney CL, Langer R, Sasisekharan R. Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation. Proc Natl Acad Sci USA. 93:1996;845-850.
46. Herr AB, Ornitz DM, Sasisekharan R, Venkataraman G, Waksman G. Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes. of outstanding interest J Biol Chem. 272:1997;16382-16389 Biophysical methods were used to characterize the binding of heparin-derived oligosaccharides to FGF-2. The results support the ability of FGF to interact with heparin in both cis and trans binding modes.
47. Kraulis PJ. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr. 24:1991;946-950.